Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03639714
Title A Study of a Personalized Neoantigen Cancer Vaccine
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Gritstone Oncology, Inc.
Indications

lung non-small cell carcinoma

gastroesophageal junction adenocarcinoma

transitional cell carcinoma

colorectal cancer

Therapies

GRT-C901 + GRT-R902 + Ipilimumab + Nivolumab

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST